Clinical Trial Update: Effects of Genistein in Postmenopausal Women With Metabolic Syndrome [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 clinical trial evaluating the effects of genistein in postmenopausal women with metabolic syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Drugs mentioned

• Genistein (genistein)

Snippet

Sponsor: University of Messina | Conditions: Metabolic Syndrome | Phase 2, Phase 3 | Status: COMPLETED